Live Breaking News & Updates on Volitionrx Limited

Stay updated with breaking news from Volitionrx limited. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Volition to Share Nu.Q® NETs Strategy Update at Upcoming Webinar

/PRNewswire/ VolitionRx Limited (NYSE American: VNRX) ("Volition"), a multi-national epigenetics company, is taking part in a webinar hosted by Edison. ....

United States , City Of , United Kingdom , Soo Romanoff , Louise Batchelor Debra Daglish , Andrew Retter , Volitionrx Limited , Edison Group , Healthcare At Edison Group , Exchange Commission , Securities Exchange , Gael Forterre , Chief Commercial Officer , United Kingdom Based Intensive Care Consultant , Medical Consultant , Managing Director , Debra Daglish , Securities Act , Securities Exchange Act , Annual Report , Quarterly Reports ,

Antech launches breakthrough in-hospital innovation, Nu.Q® Canine Cancer Test

/PRNewswire/ Antech, the veterinary diagnostics company focused on helping veterinary professionals predict, diagnose and monitor wellness and disease,. ....

Antech Heska , Mars Petcare , Jimmy Barr , Prnewswire Antech , Wisdom Panel , Waltham Petcare Science Institute , Canine Cancer Test , Heska Element , Immunodiagnostic Analyzer , Immunodiagnostics Analyzer , Chief Medical Officer , Volitionrx Limited , Belgian Volition , Mars Science , Antech Diagnostics , Health Care Amp Hospitals , Medical Equipment , Medical Pharmaceuticals , Animals Amp Pets , New Products Amp Services ,

Volition Issues Business Review 2023

HENDERSON, Nev., Jan. 4, 2024 /PRNewswire/ — VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”), a multi-national epigenetics company, has issued a Business Review of 2023, outlining its key highlights from the past year. Volition’s major achievements in 2023 include: Launching the Nu.Q® Vet Cancer Test in some significant markets through several licensing, supply and/or distribution agreements. Establishing […] ....

City Of , United Kingdom , Louise Batchelor Debra Daglish , Cameron Reynolds , Securities Exchange , Volitionrx Limited , Drug Administration , Centers Of Excellence , Exchange Commission , Business Review , Vet Cancer Test , Group Chief Executive Officer , Debra Daglish , Securities Act , Securities Exchange Act , Annual Report , Quarterly Reports ,

VolitionRx (NYSEAMERICAN:VNRX) Shares Up 10.5%

VolitionRx Limited (NYSEAMERICAN:VNRX – Get Free Report) shares traded up 10.5% during trading on Wednesday . The company traded as high as $1.19 and last traded at $1.16. 1,389,572 shares were traded during mid-day trading, a decline of 30% from the average session volume of 1,993,052 shares. The stock had previously closed at $1.05. VolitionRx […] ....

Volitionrx Limited , Dfpg Investments , Cubist Systematic Strategies , Get Free Report , Financial Advisors , Street Group , Volitionrx Daily , Nyseamerican Vnrx ,

IO Biotech And 2 Other Stocks Under $2 Insiders Are Buying - Kore Group Holdings (NYSE:KORE), IO Biotech (NASDAQ:IOBT)

The Dow Jones closed higher by over 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. ....

Brian Burkavage , Romil Bahl , Volitionrx Limited , Archibald Innes , Dow Jones , Volitionrx Ltd , Kore Group Holdings Inc , Io Biotech Inc , Group Holdings Inc , Group Holdings , Guy Archibald Innes , Volitionrx Does , Chief Executive Officer Romil Bahl , Holdings Does , Accounting Officer Brian Burkavage ,